Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 24;3(9):e003551.
doi: 10.1136/bmjopen-2013-003551.

The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey

Maria Sjölander  1 , Marie Eriksson, Eva-Lotta Glader
Affiliations

The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey

Maria Sjölander et al. BMJ Open. .

Abstract

Objectives: Adherence to preventive drug treatment is a clinical problem and we hypothesised that patients' beliefs about medicines and stroke are associated with adherence. The objective was to examine associations between beliefs of patients with stroke about stroke and drug treatment and their adherence to drug treatment.

Design: Cross-sectional questionnaire survey.

Setting: Patients with stroke from 25 Swedish hospitals were included.

Measurements: Questionnaires were sent to 989 patients to assess their perceptions about stroke (Brief Illness Perception Questionnaire, Brief IPQ), beliefs about medicines (Beliefs about Medicines Questionnaires, BMQ) and adherence to treatment (Medication Adherence Report Scale, MARS) 3 months after stroke onset. Only patients living at home were included in the analysis. The primary outcome was self-reported adherence as measured on MARS. MARS scores were dichotomised into adherent/non-adherent. Background and clinical data from the Swedish Stroke register were included.

Results: 811 patients were still living at home and 595 answered the questionnaire. Complete MARS data were available for 578 patients and 72 (12.5%) of these were classified as non-adherent. Non-adherent patients scored lower on positive beliefs as measured on BMQ-necessity (OR = 0.90, 95% CI 0.83 to 0.98) and BMQ-benefit (OR=0.77, 95% CI 0.68 to 0.87), and higher on negative beliefs as measured on BMQ-concern (OR=1.12, 95% CI 1.05 to 1.21), BMQ-overuse (OR=1.29, 95% CI 1.14 to 1.45), and BMQ-harm (OR=1.12, 95% CI 1.01 to 1.24). The Brief IPQ showed that non-adherent patients believed their current treatment to be less useful (p=0.001).

Conclusions: This study showed associations between beliefs of Swedish patients with stroke about medicines and adherence. Positive beliefs were less common and negative more common among non-adherent. To improve adherence, patients' beliefs about medicines should be considered.

Keywords: CLINICAL PHARMACOLOGY; PREVENTIVE MEDICINE; STROKE MEDICINE; THERAPEUTICS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of hospitals and patients in the study.
See this image and copyright information in PMC

References

    1. Socialstyrelsen Nationella riktlinjer för strokesjukvård 2009—Stöd för styrning och ledning (National guidelines for stroke care 2009) (in Swedish). Stockholm: The Swedish National Board of Health and Welfare, 2009
    1. World Health Organization Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003
    1. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis. Med Care 2002;40:794–811. - PubMed
    1. Glader E-L, Sjölander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:397–401 - PubMed
    1. Jin J, Sklar GE, Oh VMS, et al. Factors affecting therapeutic compliance: a review from the patient's perspective therapeutics and clinical risk management. 2008;4:269–86 - PMC - PubMed

LinkOut - more resources